Covered recipient · General Payments record
KRISTI DIANE KELLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$839.49
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.42 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $147.14 | 1 |
| Abbott Laboratories | $45.50 | 3 |
| Novo Nordisk AS | $35.24 | 2 |
| Sumitomo Pharma America, Inc. | $19.77 | 1 |
| Acerta Pharma LLC | $18.80 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.58 | 1 |
| GlaxoSmithKline, LLC. | $14.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.68 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125213603 | CMS |
| Abbott Laboratories | $13.86 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125213607 | CMS |
| Abbott Laboratories | $13.96 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125213605 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.80 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104611610 | CMS |
| GlaxoSmithKline, LLC. | $14.39 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116319370 | CMS |
| Novo Nordisk Inc | $13.89 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100330948 | CMS |
| Novo Nordisk Inc | $21.35 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545696 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.58 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151179234 | CMS |
| REVANCE THERAPEUTICS, INC. | $147.14 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147943527 | CMS |
| Sumitomo Pharma America, Inc. | $19.77 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148971628 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.